Anaveon is a biopharmaceutical company that transforms engineered cytokines into novel life-saving treatments. The first program going into clinical trials is a selective IL-2 receptor agonist.
Location: Switzerland, Basel-City, Basel
Total raised: $119.73M
Investors 3
| Date | Name | Website |
| - | Forbion | forbion.co... |
| 06.03.2024 | Syncona Pa... | synconaltd... |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.12.2021 | Series B | $119.73M | - |